Cost-effectiveness of a transvalvular microaxial flow pump in infarct-related cardiogenic shock from the perspective of German statutory health insurance

BACKGROUND: In infarct-related cardiogenic shock, a transvalvular microaxial flow pump reduced 180 day mortality but increased adverse events. We evaluated its cost-effectiveness for German statutory health insurance (SHI). RESEARCH DESIGN AND METHODS: A cohort state-transition model compared the two strategies over a lifetime horizon: a 180 day acute phase from trial outcomes, and chronic states with or without heart failure. Costs and quality-adjusted life-years (QALYs) were discounted at 3% in 2023 euros. Parameter uncertainty was assessed probabilistically and unresolved acute payments by threshold analysis. RESULTS: The pump yielded 1.06 additional QALYs at incremental costs of €38,121 and an incremental cost-effectiveness ratio of €36,083 per QALY. At an illustrative willingness-to-pay threshold of €50,000 per QALY, the probability of cost-effectiveness was 86%. Bleeding 21.8 versus 11.9%, limb ischemia 5.6 versus 1.1%. Due to the lack of arm-specific case-group data, the reference analysis assumed no between-arm difference in acute payments; net monetary benefit (NMB) remained positive below €14,703. CONCLUSIONS: Under the reference assumptions, the pump may be cost-effective for German SHI, conditional on an unresolved acute payment difference in which arm-specific routine billing data could be determined. CLINICAL TRIAL REGISTRATION: https://www.clinicaltrials.gov identifier: NCT01633502. This economic analysis was not performed separately.

Authors

Institutions

Publication Details

Journal
Expert Review of Pharmacoeconomics & Outcomes Research
Published
2026-11-18
DOI
https://doi.org/10.1080/14737167.2026.2767331
Primary Topic
Mechanical Circulatory Support Devices
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Cost-effectiveness of a transvalvular microaxial flow pump in infarct-related cardiogenic shock from the perspective of German statutory health insurance

Benjamin Birkner, Michael Buerke, Priyanka Boettger, Eva‐Maria Wild et al.
3 links
Expert Review of Pharmacoeconomics & Outcomes Research
Mechanical Circulatory Support Devices
article

Cost-effectiveness of a transvalvular microaxial flow pump in infarct-related cardiogenic shock from the perspective of German statutory health insurance

Benjamin Birkner, Michael Buerke, Priyanka Boettger, Eva‐Maria Wild, Samuel Sossalla
article en

Abstract

BACKGROUND: In infarct-related cardiogenic shock, a transvalvular microaxial flow pump reduced 180 day mortality but increased adverse events. We evaluated its cost-effectiveness for German statutory health insurance (SHI). RESEARCH DESIGN AND METHODS: A cohort state-transition model compared the two strategies over a lifetime horizon: a 180 day acute phase from trial outcomes, and chronic states with or without heart failure. Costs and quality-adjusted life-years (QALYs) were discounted at 3% in 2023 euros. Parameter uncertainty was assessed probabilistically and unresolved acute payments by threshold analysis. RESULTS: The pump yielded 1.06 additional QALYs at incremental costs of €38,121 and an incremental cost-effectiveness ratio of €36,083 per QALY. At an illustrative willingness-to-pay threshold of €50,000 per QALY, the probability of cost-effectiveness was 86%. Bleeding 21.8 versus 11.9%, limb ischemia 5.6 versus 1.1%. Due to the lack of arm-specific case-group data, the reference analysis assumed no between-arm difference in acute payments; net monetary benefit (NMB) remained positive below €14,703. CONCLUSIONS: Under the reference assumptions, the pump may be cost-effective for German SHI, conditional on an unresolved acute payment difference in which arm-specific routine billing data could be determined. CLINICAL TRIAL REGISTRATION: https://www.clinicaltrials.gov identifier: NCT01633502. This economic analysis was not performed separately.

Expert Review of Pharmacoeconomics & Outcomes Research
Universität Hamburg (DE), Justus-Liebig-Universität Gießen (DE), University of Siegen (DE), Cardio-Pulmonary Institute (DE), London School of Economics and Political Science (GB)
Good health and well-being
Mechanical Circulatory Support Devices
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon